Answers are grounded in this paper and cite their sources.
Each particular radiotherapy technique employed to treat uveal melanoma has its own set of benefits and drawbacks. The ocular oncologist can choose amongst these therapies based upon his or her clinical judgment of the relative risks and benefits. Availability of the therapy and cost to the patient remain significant factors in the ocular oncologist's choice.
No takes yet. Share an insight, caveat, or question.
Reichstein et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: